The North America Cardiac Biomarkers Testing Market would witness market growth of 10.7% CAGR during the forecast period (2019–2025).
Cardiac biomarkers are used when cardiac myocytes are damaged partially or completely, and measuring these biomarkers in serum or plasma is useful during the diagnosis of myocardial infarction. Cardiac markers are used in the diagnosis and risk stratification of patients with chest pain and suspected acute coronary syndrome, and cardiac troponin (especially troponin I) is particularly useful in the diagnosis of myocardial infection due to its superior specificity compared to other cardiac biomarkers. Individuals who note symptoms of myocardial infarction and elevated troponin I or troponin T, are now classified as non-ST-segment elevation MI (NSTEMI). North America is dominating the global market, which can be attributed to the rising demand for cardiac testing, higher CVD prevalence rate, and the growing awareness towards cardiac diagnostics solutions.
Based on Type, the market is segmented into Creatine Kinase (CK-MB), Troponins, Myoglobin, Natriuretic Peptides (BNP and NT-proBNP), Ischemia Modified Albumin and Others. Based on Application, the market is segmented into Myocardial Infarction, Congestive Heart Failure, Acute Coronary Syndrome, Atherosclerosis and Others. Based on Location of Testing, the market is segmented into Point of Care Testing and Laboratory Testing. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Trivitron Healthcare Pvt. Ltd., ABBOTT Laboratories, Siemens AG, Becton, Dickinson AND Company, Bio-Rad laboratories, Inc., Randox Laboratories Limited, Danaher Corporation, Thermo Fisher Scientific, Inc., Johnson and Johnson and Quidel Corporation.
Scope of the Study
• Creatine Kinase (CK-MB)
• Natriuretic Peptides (BNP and NT-proBNP)
• Ischemia Modified Albumin
• Myocardial Infarction
• Congestive Heart Failure
• Acute Coronary Syndrome
By Location of Testing
• Point of Care Testing
• Laboratory Testing
• Rest of North America
• Trivitron Healthcare Pvt. Ltd.
• Abbott Laboratories
• Siemens AG
• Becton, Dickinson AND Company
• Bio-Rad Laboratories, Inc.
• Randox Laboratories Limited
• Danaher Corporation
• Thermo Fisher Scientific, Inc.
• Johnson and Johnson
• Quidel Corporation
Our reports have been used by over 10K customers, including:
Brain Biomarkers Market Research Report by Product (Biomarker Analyzers and Biomarker Test Kits), by Indication (Alzheimer’s disease & other dementias, Huntington’s disease, MND & ALS, Parkinson’s disease, and Stroke), by End-Users, by Application - Global Forecast to 2025 - Cumulative Impact of COVID-19 The Global...
The Global In Vitro Diagnostics Partnering Terms and Agreements 2014-2020 report provides a detailed understanding and analysis of how and why companies enter in vitro diagnostics partnering deals. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes. This...
Cancer Biomarkers Market Research Report by Biomolecule Type (Epigenetic, Genetic, Metabolic, and Proteomic), by Cancer Type (Blood Cancer, Breast Cancer, Colorectal Cancer, Lung Cancer, and Ovarian Cancer), by Technology, by Application, by End User - Global Forecast to 2025 - Cumulative Impact of COVID-19 The Global...
The global sepsis diagnostics market is projected to grow at a CAGR of 8.5% during the forecast period. The global sepsis diagnostics market size is expected to reach USD 700 million by 2025 from USD 429 million in 2019, at a CAGR of 8.5%. The demand is expected to grow due to the rising incidence of sepsis, a growing number...
Certain factors that are driving the market growth include the increased incidence of cancer, globally, and higher acceptance of treatments for cancer in the developing regions, the paradigm shift in healthcare, from disease diagnosis to risk assessment or early diagnosis, and increasing usage of biomarkers in drug development. - Globally,...
177 pages •
By Global Industry Analysts
• Jul 2020
Global Cardiac Biomarkers Market to Reach US$10.8 Billion by the Year 2027 Amid the COVID-19 crisis, the global market for Cardiac Biomarkers estimated at US$6.2 Billion in the year 2020, is projected to reach a revised size of US$10.8 Billion by 2027, growing at a CAGR of 8.1% over the period 2020-2027.Laboratory Testing, one of the segments...
The Global Genomics Partnering Terms and Agreements 2014 to 2020 report provides an understanding and access to the Genomics partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in Genomics partnering deals Disclosed headlines, upfronts, milestones and royalties by stage...
Cancer Biomarkers Market by Profiling Technology (Omic Technologies, Imaging Technologies, Immunoassays, and Cytogenetics Based Tests), Biomolecule (Genetic Biomarkers, Protein Biomarkers, and Glyco-biomarkers), Cancer Type (Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer, Stomach Cancer, and Others), and Application...
Global Clinical Biomarkers Market to Reach $45.91 Billion by 2029 Key Questions Answered in this Report: • What are the major market drivers, challenges, and opportunities in the global clinical biomarkers market? • What are the key development strategies which are implemented by the major players...
The electrophoresis market is projected to grow at a CAGR of 6.0% during the forecast period. The electrophoresis market is expected to reach USD 3.6 billion by 2025 from USD 2.7 billion in 2020, at a CAGR of 6.0% during the forecast period. The rising incidence of cancer, infectious diseases, and genetic disorders; growth...
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.